Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Table of Contents How to Read This Chart GLP-1 Receptor Agonists and Metabolic Peptides Growth Hormone Secretagogues and GHRH Analogs Healing and Repair Peptides Immune and Antimicrobial Peptides Neuropeptides and Nootropics Reproductive and Hormonal Peptides Endogenous Signaling Peptides Factors That Affect Peptide Half-Life Why Half-Life Matters Clinically FAQ The Bottom Line References How to Read This Chart Each entry includes: Half-life : The elimination half-life (t1/2) time for plasma concentration to drop by 50% Route : Primary route of administration used in studies Steady state : Approximate time to reach stable plasma levels with regular dosing (generally 4-5 half-lives) Data quality : Whether values come from formal PK studies, FDA labeling, or preclinical/estimated data A peptide with a 7-day half-life reaches steady state in about 4-5 weeks
Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer
It demonstrates how BOC Sciences supports researchers and developers in overcoming formulation challenges and achieving optimal therapeutic performance
100% pure L-Carnitine tartrate
Single agent, canfosfamide (C, TLK286) vs pegylated liposomal doxorubicin (D) or topotecan (T) in 3rd-line treatment of platinum (P) refractory or resistant ovarian cancer (OC): phase 3 study results [Abstract]
US$ 21.14
US$ 26.03
US$ 29.81
US$ 27.52
US$ 25.53
US$ 22.44
